Entertainment
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) F
By: prnewswire_apac
- Dec 30 2024
- 0
- 0 Views
Share this page
Guest Posts by Easy Branches BLA for Kidney Cancer Imaging&url=https://easybranches.com/feed/th/entertainment/10695174&media=https://easybranches.com/feed/uploads/2024/12/5e53aa57a59606f1011dcd0ae5b88793.jpg){kind=link}
